Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05978050
Status:
RECRUITING
Last Update Posted:
2023-08-07
First Post:
2023-07-20
Brief Title:
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
Sponsor:
Biotech Pharmaceutical Co Ltd
Organization:
Biotech Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-20
First Submit QC Date:
August 3 2023
Study First Post Date:
2023-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-27
Last Update Post Date:
2023-08-07
Last Update Post Date Type:
ACTUAL